ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Advocacy
  • Artificial intelligence (AI)
  • Brain cancer
  • Breast cancer
  • ComboMATCH
  • COVID-19
  • Gastrointestinal (GI) cancer
  • Genitourinary (GU) cancer
  • Head and neck cancer
  • Health equity
  • Imaging
  • Immunotherapy
  • In memory
  • Leukemia
  • Lung cancer
  • Lymphoma
  • Mammography
  • Melanoma
  • Myelodysplastic syndrome
  • Myeloma
  • NCI-MATCH
  • Older adults
  • Pancreatic cancer
  • Pancreatic cysts
  • Patient education
  • Patient navigation
  • Patient-reported outcomes
  • Personalized treatment
  • Precision medicine
  • Prevention
  • Prostate cancer
  • Real-world data
  • Real-world evidence
  • Research results
  • Sarcoma
  • Screening for cancer
  • Side effects
  • Survivorship
  • Targeted therapy
  • Young adults
June 24, 2021
Green tea extract pills
June 24, 2021
Categories
  • New Trials

Now Enrolling: Clinical trial EA8184 is exploring if green tea extract pills can help reduce the progression of prostate cancer

This study will evaluate the effects and safety of green tea catechins in men on active surveillance for prostate cancer
Do you like it?
1 Read more
March 3, 2021
Couple with doctor
March 3, 2021
Categories
  • Editorials

COVID-19 and clinical trials: Continuing care in a pandemic

Cancer does not stop for COVID, and neither should cancer screening or treatment
Do you like it?
0 Read more
March 3, 2021
Man holding throat
March 3, 2021
Categories
  • New Trials

Now Enrolling: Clinical trial EA2174 is evaluating a new treatment approach for patients with esophagus cancer

This trial is testing if the addition of immunotherapy to the usual treatment will lead to better results for patients with esophagus or gastroesophagus cancer
Do you like it?
0 Read more
June 10, 2020
Valerie Guild headshot
June 10, 2020
Categories
  • Editorials

Remembering Valerie Guild, a tireless advocate for patients with melanoma

Valerie Guild was Founder and President of the non-profit organization AIM at Melanoma, and served as a patient advocate on ECOG-ACRIN’s Melanoma Committee for over ten years.
Do you like it?
0 Read more
Prev page
1234567
Next page

News, editorials, and perspectives for the cancer research advocacy community

✕

Categories

  • Editorials
  • New Trials
  • Ongoing Trials
  • Trial Results

Resources

  • Active ECOG-ACRIN Trials
  • Advocacy Organizations
  • Myths and Facts
STAY UP TO DATE

Subscribe to receive updates from the ECOG-ACRIN advocacy committee.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact


Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc